BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25667218)

  • 1. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
    Enesa K; Moll HP; Luong L; Ferran C; Evans PC
    FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.
    Siracuse JJ; Fisher MD; da Silva CG; Peterson CR; Csizmadia E; Moll HP; Damrauer SM; Studer P; Choi LY; Essayagh S; Kaczmarek E; Maccariello ER; Lee A; Daniel S; Ferran C
    Transplantation; 2012 Feb; 93(4):373-82. PubMed ID: 22245872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
    Lu TT; Onizawa M; Hammer GE; Turer EE; Yin Q; Damko E; Agelidis A; Shifrin N; Advincula R; Barrera J; Malynn BA; Wu H; Ma A
    Immunity; 2013 May; 38(5):896-905. PubMed ID: 23602765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
    Charan RA; Hanson R; Clemens PR
    FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection.
    Onose A; Hashimoto S; Hayashi S; Maruoka S; Kumasawa F; Mizumura K; Jibiki I; Matsumoto K; Gon Y; Kobayashi T; Takahashi N; Shibata Y; Abiko Y; Shibata T; Shimizu K; Horie T
    Eur J Pharmacol; 2006 Jul; 541(3):198-204. PubMed ID: 16765340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deubiquitinase activity of A20 is dispensable for NF-κB signaling.
    De A; Dainichi T; Rathinam CV; Ghosh S
    EMBO Rep; 2014 Jul; 15(7):775-83. PubMed ID: 24878851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation.
    Wertz IE; Newton K; Seshasayee D; Kusam S; Lam C; Zhang J; Popovych N; Helgason E; Schoeffler A; Jeet S; Ramamoorthi N; Kategaya L; Newman RJ; Horikawa K; Dugger D; Sandoval W; Mukund S; Zindal A; Martin F; Quan C; Tom J; Fairbrother WJ; Townsend M; Warming S; DeVoss J; Liu J; Dueber E; Caplazi P; Lee WP; Goodnow CC; Balazs M; Yu K; Kolumam G; Dixit VM
    Nature; 2015 Dec; 528(7582):370-5. PubMed ID: 26649818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
    Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
    J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
    Oshima N; Ishihara S; Rumi MA; Aziz MM; Mishima Y; Kadota C; Moriyama I; Ishimura N; Amano Y; Kinoshita Y
    Clin Exp Immunol; 2010 Feb; 159(2):185-98. PubMed ID: 19912257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.
    Shrikhande GV; Scali ST; da Silva CG; Damrauer SM; Csizmadia E; Putheti P; Matthey M; Arjoon R; Patel R; Siracuse JJ; Maccariello ER; Andersen ND; Monahan T; Peterson C; Essayagh S; Studer P; Guedes RP; Kocher O; Usheva A; Veves A; Kaczmarek E; Ferran C
    PLoS One; 2010 Dec; 5(12):e14240. PubMed ID: 21151899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.
    Enesa K; Zakkar M; Chaudhury H; Luong le A; Rawlinson L; Mason JC; Haskard DO; Dean JL; Evans PC
    J Biol Chem; 2008 Mar; 283(11):7036-45. PubMed ID: 18178551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.
    Moll HP; Lee A; Minussi DC; da Silva CG; Csizmadia E; Bhasin M; Ferran C
    J Biol Chem; 2014 Nov; 289(45):30912-24. PubMed ID: 25217635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
    Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
    Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
    Gui J; Yue Y; Chen R; Xu W; Xiong S
    PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
    da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
    Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
    Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
    Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
    Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.